CCB
VRTX icon

Cutter & Co Brokerage’s Vertex Pharmaceuticals VRTX Stock Holding History

Cutter & Co Brokerage’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,407
Closed -$4.08M – 169
2025
Q1 		$4.08M Sell
8,407
-3,355
-29% -$1.56M 0.96% 27
2024
Q4 		$4.74M Buy
11,762
+220
+2% +$102K 1.16% 22
2024
Q3 		$5.37M Sell
11,542
-192
-2% -$92.2K 1.21% 20
2024
Q2 		$5.5M Sell
11,734
-174
-1% -$75.5K 1.33% 15
2024
Q1 		$4.98M Buy
11,908
+116
+1% +$49K 1.22% 19
2023
Q4 		$4.8M Sell
11,792
-209
-2% -$77.2K 1.33% 15
2023
Q3 		$4.17M Sell
12,001
-109
-0.9% -$38.1K 1.22% 16
2023
Q2 		$4.26M Buy
12,110
+75
+0.6% +$25.3K 1.26% 16
2023
Q1 		$3.79M Sell
12,035
-141
-1% -$42.3K 1.18% 16
2022
Q4 		$3.52M Sell
12,176
-112
-0.9% -$34.1K 1.19% 19
2022
Q3 		$3.56M Sell
12,288
-45
-0.4% -$12.9K 1.32% 15
2022
Q2 		$3.48M Sell
12,333
-935
-7% -$250K 1.19% 21
2022
Q1 		$3.46M Buy
13,268
+838
+7% +$199K 1.03% 27
2021
Q4 		$2.73M Buy
12,430
+310
+3% +$60.3K 0.75% 38
2021
Q3 		$2.2M Buy
12,120
+225
+2% +$43.9K 0.52% 61
2021
Q2 		$2.4M Buy
11,895
+1,050
+10% +$220K 0.55% 59
2021
Q1 		$2.33M Buy
10,845
+6,615
+156% +$1.45M 0.57% 57
2020
Q4 		$1M Buy
+4,230
New +$971K 0.26% 87

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cutter & Co Brokerage's VRTX Position: Q2 2025 in Review

Cutter & Co Brokerage sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 8,407 shares — an estimated $4.08M sold.

Cutter & Co Brokerage first reported a position in VRTX in Q4 2020 and held it in 18 quarters. The position peaked at $5.5M in Q2 2024. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Cutter & Co Brokerage reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Cutter & Co Brokerage sold 8,407 Vertex Pharmaceuticals shares in Q2 2025, an estimated $4.08M.
  • Cutter & Co Brokerage first reported a position in Vertex Pharmaceuticals in Q4 2020 and held it in 18 quarters.
  • Cutter & Co Brokerage's Vertex Pharmaceuticals position peaked at $5.5M in Q2 2024.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Cutter & Co Brokerage's 13F filing for Q2 2025.